Cytophage Launches Ready-to-Use Lyophilized Phage Tablets to Improve Gut Health in Poultry

Winnipeg, August 15 2024. Cytophage Technologies Ltd. (TSXV:CYTO) (“Cytophage” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal health and human health, is pleased to announce the launch of a simplified application option for bacteriophages that can treat multiple types of bacteria, such as E. coli and Salmonella, throughout the lifecycle of a chicken.

The release as fetched from its publisher. cytophage.com ↗